Beckman Coulter accelerates blood-based Alzheimer’s testing
23 Jun 2025
Kevin O’Reilly, President of Beckman Coulter Diagnostics, reflects on two years of progress since the launch of the DxI 9000 Analyzer at EuroMedLab 2023. This high-sensitivity, high-throughput immunoassay analyzer — capable of testing up to 450 samples per hour — has since been enhanced with over 61 new assays, covering key clinical areas including cardiac health, sepsis, anemia, reproductive health, and infectious disease.
In this exclusive EuroMedLab 2025 update, O’Reilly also reveals groundbreaking advancements in blood-based testing for Alzheimer’s disease, including a Breakthrough Device Designation from the FDA for Beckman Coulter’s p-tau217 / Aβ1-42 assay. This test aims to replace expensive and invasive diagnostics like PET scans and lumbar punctures with scalable, community-accessible blood testing.
Beckman Coulter’s global R&D teams are leading innovation in neurodegenerative biomarkers, collaborating with the Davos Alzheimer’s Collaborative and Global Alzheimer’s Task Force to bring precision diagnostics to more patients, sooner.
Watch now to see how Beckman Coulter is transforming access to Alzheimer’s diagnostics and redefining core lab performance.
This video was filmed at EuroMedLab2025.
About the company
Beckman Coulter Diagnostics
Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating-type lease payments, represents approximately 78 percent of the company s 2007 annual revenue of $2.76 billion. For more information, visit www.beckmancoulter.com.
Related products
Request Quote for All Products
DxI 9000 Access Immunoassay Analyzer
Beckman Coulter DiagnosticsThe award-winning DxI 9000 Analyzer sets a new standard for today’s busy labs. With meaningful innovations that amplify your impact, liberate you from the laborious, and power your performance across your health system, this high-throughput immunoassay analyzer takes diagnostics to the next level.
